2019 Recommendations of the AMA Opioid Task Force
AMA Opioid Task Force issues new recommendations to urge policymakers to protect patients' access to evidence-based treatment and remove barriers to comprehensive pain care
CDC Opioid Prescribing Guidelines
This guideline provides recommendations for primary care clinicians who are prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life care.
CDC Guidelines at a Glance
CDC guideline for prescribing opioids for chronic pain.
FDA issues warning for products marketed to treat opioid withdrawal
The FDA sent a warning letter to EPH Technologies, accusing it of marketing and selling unapproved drugs.
Framing Opioid Prescribing Guidelines for Acute Pain: Developing the Evidence
This report recommends two frameworks—an analytic framework and an evidence evaluation framework—that medical professional societies, health care organizations, and state, national, and local agencies could use to develop CPGs for prescribing opioids to manage acute pain.
Minnesota Opioid Prescribing Guidelines, First Edition 2018
This is the first edition of the Minnesota Opioid Prescribing Guidelines.
The COVID-19 Pandemic: Practice and Policy Considerations For Patients with Opioid Use Disorder
This article details US policy updates that are loosening restrictions around MOUD prescribing in light of COVID-19.
Beyond Antibiotics: A Practical Guide for the Infectious Disease Physician to Treat Opioid Use Disorder in the Setting of Associated Infectious Diseases
Guidelines for comanagement of OUD and infectious diseases
The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder – 2020 Focused Update
The ASAM National Practice Guideline 2020 focused update is intended to inform and empower clinicians, health system administrators, criminal justice system administrators, and policymakers who are interested in implementing evidence-based practices to improve outcomes for individuals with OUD. This is especially critical in the context of the ongoing COVID-19 emergency, which threatens to curtail patient access to evidence-based treatment.
